Drug Enforcement Administration Controlled Substances; Established 1993
Aggregate Production Quotas

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Final rule establishing 1993 aggregate production quotas.

SUMMARY: The interim rule (58 FR 51382, October 1, 1993) which established
1993 revised aggregate production quotas for some controlled substances in
Schedules I and II, as required under the Controlled Substances Act (CSA) (21
U.S.C. 826) is adopted without change.

EFFECTIVE DATE: January 4, 1994.

FOR FURTHER INFORMATION CONTACT:

Howard McClain, Jr., Chief, Drug & Chemical Evaluation Section, Drug
Enforcement Administration, Washington, DC 20537, telephone: (202) 307Ä7183.

SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances Act, (21
U.S.C. 826), requires the Attorney General to establish aggregate production
quotas for controlled substances in Schedules I and II each year. This
responsibility has been delegated to the Administrator of the Drug Enforcement
Administration pursuant to  0.100 of title 28 of the Code of Federal
Regulations.

On October 1, 1993, an interim rule establishing revised 1993 aggregate
production quotas for controlled substances in Schedules I and II was
published in the Federal Register (58 FR 51382). One comment was received from
a company supporting the use of the interim rule in establishing aggregate
production quotas under certain circumstances. The interim rule is adopted
without change.

This rule is not a significant regulatory action and therefore has not been
reviewed by the Office of Management and Budget pursuant to Executive Order
12866.

These actions have been analyzed in accordance with the principles and
criteria contained in Executive Order 12612, and it has been determined that
this matter does not have sufficient federalism implications to warrant the
preparation of a Federalism Assessment.

The Administrator hereby certifies that this action will have no significant
impact upon small entities whose interests must be considered under the
Regulatory Flexibility Act, 5 U.S.C. 601, et seq. The establishment of annual
aggregate production quotas for Schedules I and II controlled substances is
mandated by law and by international commitments of the United States. Such
quotas impact predominantly upon major manufacturers of the affected
controlled substance.

Therefore, under the authority vested in the Attorney General by section 306
of the CSA of 1970 (21 U.S.C. 826) and delegated to the Administrator by 
0.100 of title 28 of the Code of Federal Regulations, the Administrator of the
DEA hereby establishes the following revised 1993 aggregate production quotas
for the listed controlled substances, expressed in grams of anhydrous base:

 [col head 1] Basic class  [col head 1] Established 1993 quotas (in grams)

Schedule I:

Methaqualone 	12

3,4-Methylenedioxyamphetamine 	12

3,4-Methylenedioxymethamphetamine 	12

Schedule II:

Dextropropoxyphene 	115,162,000

Methadone (for sale) 	3,675,000

Methadone Intermediate (for conv) 	4,598,000

Oxycodone (for sale) 	3,520,000

Phencyclidine 	54

Thebaine 	7,795,000

Dated: December 22, 1993.

Stephen H. Greene,

Acting Administrator of Drug Enforcement.

[FR Doc. 94Ä108 Filed 1Ä3Ä94; 8:45 am]

BILLING CODE 4410Ä09ÄM